AP1M1 Knockout Jurkat Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population targeting the AP1M1 gene in human Jurkat T lymphocytes. This product consists of a heterogeneous cell pool generated through CRISPR/Cas9-mediated gene disruption, creating a functional knockout model without clonal selection biases. It is specifically designed for dissecting the roles of the AP-1 adaptor complex in clathrin-mediated trafficking and lysosomal protein sorting.
The Jurkat host cell line is an immortalized T lymphocyte line originally derived from the peripheral blood of a 14-year-old male with acute T-cell leukemia. Extensively used to study T cell receptor signaling, cytokine production, and leukemogenesis, Jurkat cells exhibit robust proliferation and well-characterized molecular pathways. Their ease of genetic manipulation makes them an ideal platform for generating knockout models, enabling direct interrogation of how trafficking factors like AP1M1 influence T cell function and leukemia biology.
AP1M1 encodes the mu1 subunit of the AP-1 adaptor complex, a key component in clathrin-coated vesicle formation at the trans-Golgi network (TGN). The mu1 subunit recognizes tyrosine-based sorting motifs (YXX??) on cargo cytoplasmic tails, facilitating their incorporation into vesicles. AP1M1 interacts with the other AP-1 subunits (AP1G1, AP1B1, AP1S1), clathrin, and the GTPase ARF1, and its recruitment is regulated by Rab GTPases and phosphoinositides such as PI4P. Downstream, AP-1 mediates the trafficking of lysosomal hydrolases like cathepsin D, MHC class I molecules, integrin alpha chains, and cytotoxic granule components. Knockout of AP1M1 disrupts cargo selection and coat assembly, leading to defective lysosomal enzyme maturation and altered cell surface receptor expression, making this model valuable for studying MEDNIK syndrome and lysosomal storage disorders.
In Jurkat T lymphocytes, AP1M1 loss impairs AP-1-dependent sorting pathways critical for immune cell function. Surface levels of MHC class I and integrins, both known AP-1 cargoes, are likely reduced, potentially compromising antigen presentation and cell adhesion. Lysosomal enzyme trafficking defects can disrupt cytotoxic granule maturation, affecting T cell-mediated killing. As a model for T-cell acute lymphoblastic leukemia, AP1M1 knockout enables investigation of how trafficking perturbations influence leukemic cell survival, proliferation, and immune evasion.
This polyclonal knockout population supports a range of experimental assays. Confocal microscopy can track subcellular redistribution of cargoes like LAMP1. Western blot analysis of cathepsin D maturation provides a functional lysosomal readout. Flow cytometry enables quantification of surface MHC class I and integrin levels. Co-immunoprecipitation assesses AP-1 complex integrity, and RNA-seq reveals transcriptional responses to trafficking stress. It is suitable for screening small-molecule modulators and for disease modeling. For further information, please contact Ascent Research.
